ALX Oncology Holdings Inc. (ALXO)

ALX Oncology Holdings Statistics

Total Valuation

ALXO has a market cap or net worth of $269.12 million. The enterprise value is $141.34 million.

Market Cap	269.12M
Enterprise Value	141.34M

Important Dates

The last earnings date was Friday, May 8, 2026, before market open.

Earnings Date	May 8, 2026
Ex-Dividend Date	n/a

Share Statistics

ALXO has 134.56 million shares outstanding. The number of shares has increased by 25.44% in one year.

Current Share Class	134.56M
Shares Outstanding	134.56M
Shares Change (YoY)	+25.44%
Shares Change (QoQ)	+92.64%
Owned by Insiders (%)	1.23%
Owned by Institutions (%)	38.57%
Float	86.04M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.80
P/TBV Ratio	1.80
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 7.21, with a Debt / Equity ratio of 0.06.

Current Ratio	7.21
Quick Ratio	6.95
Debt / Equity	0.06
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-57.62

Financial Efficiency

Return on equity (ROE) is -74.17% and return on invested capital (ROIC) is -41.55%.

Return on Equity (ROE)	-74.17%
Return on Assets (ROA)	-36.76%
Return on Invested Capital (ROIC)	-41.55%
Return on Capital Employed (ROCE)	-55.64%
Weighted Average Cost of Capital (WACC)	6.76%
Revenue Per Employee	n/a
Profits Per Employee	-$2.07M
Employee Count	43
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +341.88% in the last 52 weeks. The beta is 0.41, so ALXO's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	+341.88%
50-Day Moving Average	1.91
200-Day Moving Average	1.58
Relative Strength Index (RSI)	57.25
Average Volume (20 Days)	941,000

Short Selling Information

The latest short interest is 2.21 million, so 1.64% of the outstanding shares have been sold short.

Short Interest	2.21M
Short Previous Month	2.05M
Short % of Shares Out	1.64%
Short % of Float	2.56%
Short Ratio (days to cover)	2.09

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-87.99M
Pretax Income	-88.87M
Net Income	-88.87M
EBITDA	-87.35M
EBIT	-87.99M
Earnings Per Share (EPS)	-$1.34

Balance Sheet

The company has $140.32 million in cash and $8.51 million in debt, with a net cash position of $131.81 million or $0.98 per share.

Cash & Cash Equivalents	140.32M
Total Debt	8.51M
Net Cash	131.81M
Net Cash Per Share	$0.98
Equity (Book Value)	151.35M
Book Value Per Share	1.12
Working Capital	125.39M

Cash Flow

In the last 12 months, operating cash flow was -$78.13 million and capital expenditures -$202,000, giving a free cash flow of -$78.33 million.

Operating Cash Flow	-78.13M
Capital Expenditures	-202,000
Depreciation & Amortization	645,000
Net Borrowing	-2.67M
Free Cash Flow	-78.33M
FCF Per Share	-$0.58

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ALXO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.44%
Shareholder Yield	-25.44%
Earnings Yield	-32.53%
FCF Yield	-28.68%

Analyst Forecast

The average price target for ALXO is $4.60, which is 130.00% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.60
Price Target Difference	130.00%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	3